Ọdịmma adịchaghị mma mgbochi tumor API Docetaxel CAS 114977-28-5

Ozi ngwaahịa

Aha:Docetaxel

Nọmba CAS:114977-28-5

Usoro kemịkalụ:C45H57NO14

Nkọwapụta:99%

Agba:ọcha ntụ ntụ

Isi mmalite:Semi-synthesized na 10-DAB

Ụdị:API

Ọrụ

Maka ọgwụgwọ ọrịa kansa ara dị elu, ọrịa kansa akpa ume na-abụghị obere cell.A na-ejikwa ya na-agwọ etuto dị ka kansa isi na olu, ọrịa cancer akpa ume obere cell, ọrịa afọ afọ, na ọrịa cancer ovarian.

Dị ka paclitaxel, ọ na-enwe mmetụta dị mma na ọrịa cancer akpa ume na-abụghị obere cell na ọrịa ara ara, a pụkwara iji ya mee ihe maka ọrịa cancer isi na olu na ọrịa cancer ovarian.

Akụkọ ihe mere eme nke Hande GMP

1.In 1996, àgwà usoro e guzobere na nwetara DMF.

2.In 2004, FDA on-site nnyocha nwetara CGMP akwụkwọ.

3.Na 2009, ọkara-synthetic paclitaxel DMF na eke paclitaxel CEP nwetara.

4.N'afọ 2011, e nwetara paclitaxel CEP semi-synthetic.

5.In 2012, gafere nyocha TGA na saịtị, nweta asambodo GMP, wee gafee nyocha saịtị FDA.

6.In 2013, gafere CGMP saịtị.

7.In 2015, India e debara aha na Japan e debanyere aha.

Hande mmepụta ike

Usoro mmepụta:Ụbọchị 7.

Ike mmepụta Hande:e nwere ngwaahịa ngwaahịa, e nwere usoro, na uka mmepụta ga-ekwe omume.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.

Yunnan hande Biotechnology Co., Ltd., tọrọ ntọala na August 1993, bụ ụlọ ọrụ teknụzụ dị elu nke ọkachamara na nyocha na mmepe biotechnology.Mgbe ọtụtụ afọ nke mmepe gasịrị, hande eguzobewo usoro dị mma zuru oke, na-achịkwa àgwà ngwaahịa dịka ụkpụrụ dị elu si dị, ma mee ka uru mmepụta nke mmepụta ihe dị elu.Ngwaahịa ya agafeela asambodo nke iwu na ụkpụrụ mba dị iche iche, wee bụrụ onye nrụpụta akụrụngwa akụrụngwa nke na-eme onye ọ bụla nwee ahụ iru ala.